1 | new concept pharma our | | | | | | | 3 | 0.81% |
2 | new concept pharma new | | | | | | | 2 | 0.54% |
3 | concept pharma new concept | | | | | | | 2 | 0.54% |
4 | variteks babycord genacol contact | | | | | | | 2 | 0.54% |
5 | new concept pharma trade | | | | | | | 2 | 0.54% |
6 | concept pharma trade company | | | | | | | 2 | 0.54% |
7 | pharma trade company is | | | | | | | 2 | 0.54% |
8 | a fast growing medical | | | | | | | 2 | 0.54% |
9 | fast growing medical and | | | | | | | 2 | 0.54% |
10 | 4bases certest neb zeptometrix | | | | | | | 2 | 0.54% |
11 | pharmaceutical company working in | | | | | | | 2 | 0.54% |
12 | nanopore technologies euroimmun omixon | | | | | | | 2 | 0.54% |
13 | company working in qatar | | | | | | | 2 | 0.54% |
14 | pharma new concept pharma | | | | | | | 2 | 0.54% |
15 | balance sheet to enable | | | | | | | 1 | 0.27% |
16 | investments strengthen the companies | | | | | | | 1 | 0.27% |
17 | of our field forces | | | | | | | 1 | 0.27% |
18 | our field forces and | | | | | | | 1 | 0.27% |
19 | field forces and ground | | | | | | | 1 | 0.27% |
20 | forces and ground teams | | | | | | | 1 | 0.27% |
21 | in qatar implement a | | | | | | | 1 | 0.27% |
22 | networks in qatar implement | | | | | | | 1 | 0.27% |
23 | marketing networks in qatar | | | | | | | 1 | 0.27% |
24 | and marketing networks in | | | | | | | 1 | 0.27% |
25 | and ground teams establish | | | | | | | 1 | 0.27% |
26 | ground teams establish more | | | | | | | 1 | 0.27% |
27 | efficient organizational and cost | | | | | | | 1 | 0.27% |
28 | strengthen the companies sales | | | | | | | 1 | 0.27% |
29 | organizational and cost structure | | | | | | | 1 | 0.27% |
30 | strengthened balance sheet to | | | | | | | 1 | 0.27% |
31 | product investments strengthen the | | | | | | | 1 | 0.27% |
32 | and cost structure enhance | | | | | | | 1 | 0.27% |
33 | cost structure enhance the | | | | | | | 1 | 0.27% |
34 | new product investments strengthen | | | | | | | 1 | 0.27% |
35 | and new product investments | | | | | | | 1 | 0.27% |
36 | the expansion of our | | | | | | | 1 | 0.27% |
37 | structure enhance the companies | | | | | | | 1 | 0.27% |
38 | profile and resources use | | | | | | | 1 | 0.27% |
39 | and resources use a | | | | | | | 1 | 0.27% |
40 | strategic and new product | | | | | | | 1 | 0.27% |